Format

Send to

Choose Destination
Drug Saf. 2015 Sep;38(9):845. doi: 10.1007/s40264-015-0329-1.

Erratum to: Methodological Approaches to Evaluate the Impact of FDA Drug Safety Communications.

Author information

1
Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Suite 3030, 1620 Tremont Street, Boston, MA, 02120, USA, akesselheim@partners.org.
PMID:
26201399
DOI:
10.1007/s40264-015-0329-1

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center